Vontobel Holding Ltd. Repligen Corp Transaction History

Vontobel Holding Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$170.78 - $208.42 $303,476 - $370,362	-1,777 Reduced 57.88%	1,293 $237,000
Q1 2023 Jun 03, 2024	BUY	$154.26 - $198.1 $37,330 - $47,940	242 Added 18.72%	1,535 $258,000
Q1 2023 Apr 12, 2023	BUY	$154.26 - $198.1 $473,578 - $608,167	3,070 New	3,070 $516,000
Q1 2021 May 11, 2021	SELL	$180.37 - $226.26 $1.36 Million - $1.7 Million	-7,515 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $1.11 Million - $1.55 Million	7,515 New	7,515 $1.44 Million

476

54.5M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.87B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.